It has recently been shown that the urological catheter included in the authorized packaging of the medicinal product Miturox (mitomycin 40 mg), powder and solvent for intravesical solution, has been tested by the manufacturer for urinary drainage but not specifically for intravesical instillation.

To avoid a possible shortage of mitomycin-based medicinal products and thus to ensure therapeutic continuity for patients being treated, it is considered appropriate not to interrupt the distribution of Miturox packs.

Users are therefore invited to assess the need to use an alternative catheter for intravesical instillation of the medicinal product in question.